Cargando…

Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection

Background: Cryptococcal meningitis is one of the most devastating infections, particularly in HIV-infected individuals. The increased use of immunosuppressants led to an increase in the incidence of cryptococcosis in HIV-uninfected individuals. This study aimed to compare the characteristics betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Teekaput, Chutithep, Yasri, Saowaluck, Chaiwarith, Romanee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051108/
https://www.ncbi.nlm.nih.gov/pubmed/36986349
http://dx.doi.org/10.3390/pathogens12030427
_version_ 1785014794268442624
author Teekaput, Chutithep
Yasri, Saowaluck
Chaiwarith, Romanee
author_facet Teekaput, Chutithep
Yasri, Saowaluck
Chaiwarith, Romanee
author_sort Teekaput, Chutithep
collection PubMed
description Background: Cryptococcal meningitis is one of the most devastating infections, particularly in HIV-infected individuals. The increased use of immunosuppressants led to an increase in the incidence of cryptococcosis in HIV-uninfected individuals. This study aimed to compare the characteristics between groups. Methods: This retrospective cohort study was conducted from 2011 to 2021 in northern Thailand. Individuals diagnosed with cryptococcal meningitis aged ≥15 years were enrolled onto the study. Results: Out of 147 patients, 101 were individuals infected with HIV and 46 were non-infected. Factors associated with being infected with HIV included age < 45 years (OR 8.70, 95% CI 1.78–42.62), white blood cells < 5000 cells/cu.mm. (OR 7.18, 95% CI 1.45–35.61), and presence of fungemia (OR 5.86, 95% CI 1.17–42.62). Overall, the mortality rate was 24% (18% in HIV-infected vs. 37% in HIV-uninfected individuals, p-value = 0.020). Factors associated with mortality included concurrent pneumocystis pneumonia (HR 5.44, 95% CI 1.55–19.15), presence of alteration of consciousness (HR 2.94, 95% CI 1.42–6.10), infection caused by members of C. gattii species complex (HR 4.19, 95% CI 1.39–12.62), and anemia (HR 3.17, 95% CI 1.17–8.59). Conclusions: Clinical manifestations of cryptococcal meningitis differed between patients with and without HIV-infection in some aspects. Increasing awareness in physicians of this disease in HIV-uninfected individuals may prompt earlier diagnosis and timely treatment.
format Online
Article
Text
id pubmed-10051108
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100511082023-03-30 Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection Teekaput, Chutithep Yasri, Saowaluck Chaiwarith, Romanee Pathogens Article Background: Cryptococcal meningitis is one of the most devastating infections, particularly in HIV-infected individuals. The increased use of immunosuppressants led to an increase in the incidence of cryptococcosis in HIV-uninfected individuals. This study aimed to compare the characteristics between groups. Methods: This retrospective cohort study was conducted from 2011 to 2021 in northern Thailand. Individuals diagnosed with cryptococcal meningitis aged ≥15 years were enrolled onto the study. Results: Out of 147 patients, 101 were individuals infected with HIV and 46 were non-infected. Factors associated with being infected with HIV included age < 45 years (OR 8.70, 95% CI 1.78–42.62), white blood cells < 5000 cells/cu.mm. (OR 7.18, 95% CI 1.45–35.61), and presence of fungemia (OR 5.86, 95% CI 1.17–42.62). Overall, the mortality rate was 24% (18% in HIV-infected vs. 37% in HIV-uninfected individuals, p-value = 0.020). Factors associated with mortality included concurrent pneumocystis pneumonia (HR 5.44, 95% CI 1.55–19.15), presence of alteration of consciousness (HR 2.94, 95% CI 1.42–6.10), infection caused by members of C. gattii species complex (HR 4.19, 95% CI 1.39–12.62), and anemia (HR 3.17, 95% CI 1.17–8.59). Conclusions: Clinical manifestations of cryptococcal meningitis differed between patients with and without HIV-infection in some aspects. Increasing awareness in physicians of this disease in HIV-uninfected individuals may prompt earlier diagnosis and timely treatment. MDPI 2023-03-08 /pmc/articles/PMC10051108/ /pubmed/36986349 http://dx.doi.org/10.3390/pathogens12030427 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Teekaput, Chutithep
Yasri, Saowaluck
Chaiwarith, Romanee
Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
title Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
title_full Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
title_fullStr Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
title_full_unstemmed Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
title_short Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
title_sort cryptococcal meningitis: differences between patients with and without hiv-infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051108/
https://www.ncbi.nlm.nih.gov/pubmed/36986349
http://dx.doi.org/10.3390/pathogens12030427
work_keys_str_mv AT teekaputchutithep cryptococcalmeningitisdifferencesbetweenpatientswithandwithouthivinfection
AT yasrisaowaluck cryptococcalmeningitisdifferencesbetweenpatientswithandwithouthivinfection
AT chaiwarithromanee cryptococcalmeningitisdifferencesbetweenpatientswithandwithouthivinfection